Identification of cystic fibrosis mutations in the United Arab Emirates
✍ Scribed by Philippe M. Frossard; Emmanuelle Girodon; Kenneth P. Dawson; Nada Ghanem; François Plassa; Gilles G. Lestringant; Michel Goossens
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 45 KB
- Volume
- 11
- Category
- Article
- ISSN
- 1059-7794
No coin nor oath required. For personal study only.
✦ Synopsis
We have designed a study aimed at identifying the genetic mutations responsible for cystic fibrosis (CF) in the population of the United Arab Emirates. The prevalence of CF in the UAE is at least 1/15,000 live births and the disease is associated with very severe clinical presentations.
We have investigated 17 unrelated families.Ten UAE national families were of Bedouin descent: all 15 CF patients, who presented with very severe forms of the disease, were homozygous for a S549R mutation due to a T->G transversion at nucleotide position 1779. Amongst a distinct population of Baluch origin, CF patients from 6 out of 7 affected families were DF508 homozyotes.
Hence, the unique distribution of CF mutations in the United Arab Emirates -two mutations, S549R and F508, characterize so far 94% of CF families -should allow efficient organizing and delivering of CF carrier screening programmes on the country's relatively limited population size.
📜 SIMILAR VOLUMES
The suggested incidence of cystic fibrosis (CF) in Asian migrants (Indians and Pakistanis) in the United Kingdom is about 1 in 10,000 to 12,000 [Goodchild et al., 1974]. There are no large studies on CF in Asian Indians. The disorder is thought to be rare and most studies from the Asian subcontinent